(2S)-2-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-4-methylpentanoic acid,dihydrochloride

Names

[ CAS No. ]:
57533-05-8

[ Name ]:
(2S)-2-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-4-methylpentanoic acid,dihydrochloride

[Synonym ]:
L-Leucine-4-antipyrineamide dihydrochloride
WK 30 dihydrochloride
L-Leucine,N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-,dihydrochloride
(2S)-2-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-4-methylpentanoic acid dihydrochloride

Chemical & Physical Properties

[ Boiling Point ]:
469.6ºC at 760 mmHg

[ Molecular Formula ]:
C17H25Cl2N3O3

[ Molecular Weight ]:
390.30500

[ Flash Point ]:
237.8ºC

[ Exact Mass ]:
389.12700

[ PSA ]:
76.26000

[ LogP ]:
4.07260

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
OH3165500
CHEMICAL NAME :
L-Leucine, N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol -4-yl)-, dihydrochloride
CAS REGISTRY NUMBER :
57533-05-8
LAST UPDATED :
199706
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C17-H23-N3-O3.2Cl-H
MOLECULAR WEIGHT :
390.35

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3010 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PMHBAH Polish Medical Sciences and History Bulletin. (Chicago, IL) V.1-15, 1956-76. Discontinued. Volume(issue)/page/year: 17(4),323,1974 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
5600 mg/kg/56D-I
TOXIC EFFECTS :
Autonomic Nervous System - smooth muscle relaxant (mechanism undefined, spasmolytic) Behavioral - antipsychotic Blood - changes in leukocyte (WBC) count
REFERENCE :
PMHBAH Polish Medical Sciences and History Bulletin. (Chicago, IL) V.1-15, 1956-76. Discontinued. Volume(issue)/page/year: 17(4),323,1974

Related Compounds

  • 1-Butyl-3-(2,2-dimethylthietan-3-yl)thiourea
  • N-(6-Bromoimidazo[1,2-a]pyrazin-2-yl)-1-ethyl-2-methylimidazole-4-sulfonamide
  • (2R)-1-(4-chloro-2-methylphenyl)propan-2-amine
  • 1-(5-Methyl-1,4-oxazepan-4-yl)prop-2-en-1-one
  • n-{2-Oxabicyclo[4.2.0]octan-7-yl}prop-2-enamide
  • 1-[3-(1-Methylimidazol-2-yl)piperidin-1-yl]prop-2-en-1-one
  • 1-{4-[(1H-1,2,3-triazol-1-yl)methyl]piperidin-1-yl}prop-2-en-1-one
  • 1-[2-(1,2,4-Oxadiazol-3-yl)azepan-1-yl]prop-2-en-1-one
  • n,n-Dimethyl-2-[1-(prop-2-enoyl)piperidin-4-yl]acetamide
  • 4-(3,3-Difluoropyrrolidin-1-yl)butanoic acid hydrochloride
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.